Paper31330261
Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
Ezzelarab MB and 9 others. Transpl Immunol, 2019. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation. Papers, record 31330261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31330261
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transplantation | Major topic |
| Graft Rejection | Major topic |
| Kidney Transplantation | Major topic |
| Myeloid-Derived Suppressor Cells | Major topic |
| T-Lymphocytes | Major topic |
| Abatacept | |
| Animals | |
| Cells, Cultured | |
| Disease Models, Animal | |
| Feasibility Studies | |
| Histocompatibility Antigens | |
| Humans | |
| Immune Tolerance | |
| Immunosuppressive Agents | |
| Macaca mulatta | |
| Sirolimus | |
| Transplantation, Autologous | |
| Transplantation, Homologous |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 AI091197 | NIAID NIH HHS | United States | U01AI091197 | PubMed and NIH | NIH RePORTER |
| U19 AI131453 | NIAID NIH HHS | United States | U19AI131453 | PubMed | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24103111 | Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion. | Am J Transplant | 2013 | https://conductscience.org/library/papers/24103111 | PubMed |
| 2 | 27653226 | Comparative Study of the Immunoregulatory Capacity of In Vitro Generated Tolerogenic Dendritic Cells, Suppressor Macrophages, and Myeloid-Derived Suppressor Cells. | Transplantation | 2016 | https://conductscience.org/library/papers/27653226 | PubMed |
| 3 | 31027947 | Transplant research in nonhuman primates to evaluate clinically relevant immune strategies in organ transplantation. | Transplant Rev (Orlando) | 2019 | https://conductscience.org/library/papers/31027947 | PubMed |
| 4 | 25834108 | G-CSF mobilizes CD34+ regulatory monocytes that inhibit graft-versus-host disease. | Sci Transl Med | 2015 | https://conductscience.org/library/papers/25834108 | PubMed |
| 5 | 23562036 | Leukapheresis protocol for nonhuman primates weighing less than 10 kg. | J Am Assoc Lab Anim Sci | 2013 | https://conductscience.org/library/papers/23562036 | PubMed |
| 6 | 19941314 | Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. | Eur J Immunol | 2010 | https://conductscience.org/library/papers/19941314 | PubMed |
| 7 | 26301174 | Monocyte-Derived Suppressor Cells in Transplantation. | Curr Transplant Rep | 2015 | https://conductscience.org/library/papers/26301174 | PubMed |
| 8 | 26680373 | Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates. | Transplantation | 2016 | https://conductscience.org/library/papers/26680373 | PubMed |
| 9 | 29348500 | Myeloid-derived suppressor cells coming of age. | Nat Immunol | 2018 | https://conductscience.org/library/papers/29348500 | PubMed |
| 10 | 27381735 | Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. | Nat Commun | 2016 | https://conductscience.org/library/papers/27381735 | PubMed |
| 11 | 29509288 | Myeloid-derived suppressor cells increase and inhibit donor-reactive T cell responses to graft intestinal epithelium in intestinal transplant patients. | Am J Transplant | 2018 | https://conductscience.org/library/papers/29509288 | PubMed |
| 12 | 22627860 | Regulatory immune cells in transplantation. | Nat Rev Immunol | 2012 | https://conductscience.org/library/papers/22627860 | PubMed |
| 13 | 20807889 | Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. | Blood | 2010 | https://conductscience.org/library/papers/20807889 | PubMed |
| 14 | 20073041 | Development and function of myeloid-derived suppressor cells generated from mouse embryonic and hematopoietic stem cells. | Stem Cells | 2010 | https://conductscience.org/library/papers/20073041 | PubMed |
| 15 | 19681826 | Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. | Am J Transplant | 2009 | https://conductscience.org/library/papers/19681826 | PubMed |
| 16 | 11782259 | Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates. | Immunol Rev | 2001 | https://conductscience.org/library/papers/11782259 | PubMed |
| 17 | 25943210 | Rapamycin Prolongs Cardiac Allograft Survival in a Mouse Model by Inducing Myeloid-Derived Suppressor Cells. | Am J Transplant | 2015 | https://conductscience.org/library/papers/25943210 | PubMed |
| 18 | 29311384 | Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment. | J Immunol | 2018 | https://conductscience.org/library/papers/29311384 | PubMed |
| 19 | 18097035 | Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. | J Immunol | 2008 | https://conductscience.org/library/papers/18097035 | PubMed |
| 20 | 28502091 | Increased Pretransplant Frequency of CD28+ CD4+ TEM Predicts Belatacept-Resistant Rejection in Human Renal Transplant Recipients. | Am J Transplant | 2017 | https://conductscience.org/library/papers/28502091 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35874716 | Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity. | Front Immunol | 2022 | https://conductscience.org/library/papers/35874716 | PubMed |
| 33708227 | Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions. | Front Immunol | 2021 | https://conductscience.org/library/papers/33708227 | PubMed |
| 33582607 | Myeloid-derived suppressor cells as cellular immunotherapy in transplantation and autoimmune diseases. | Cell Immunol | 2021 | https://conductscience.org/library/papers/33582607 | PubMed |
| 33381125 | Detection and Monitoring of Regulatory Immune Cells Following Their Adoptive Transfer in Organ Transplantation. | Front Immunol | 2020 | https://conductscience.org/library/papers/33381125 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31330261
GET https://conductscience.org/api/papers/v1/31330261/references?page=2